Corpus callosum abnormalities at term-equivalent age are associated with language development at two years corrected age in infants born very preterm

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Supported by the National Institutes of Health from the National Institute of Neurological Disorders and Stroke (R01-NS094200, R01-NS096037, and R01-EB029944) to N.A.P. and from the National Center for Advancing Translational Sciences (2UL1TR001425-05A1) to K.K.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Cincinnati Childrens Hospital institutional review board approved the study, and the review boards of the other participating hospitals approved the study based on established reciprocity agreements.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes